Bryan Boulden
Contributor since: 2014
Latest Articles
Teva: Buy For Today's Value And Tomorrow's Growth
CVS: Thanks Mylan! Investors Should Seize The Opportunity To Buy CVS At Significant Discount
Disney: Can Mickey Make It To Street's FY '17 EPS Target?
Time To Bail On Boeing
Disney: A Look At Cord Cutting In The First Quarter
Amgen: Q1 Results Show My Bull Thesis Likely Too Conservative
Gilead: Told You So, And It Gets Worse From Here
Gilead: The Hits Keep Coming
Amgen: Buy For The Value, Stay For The Growth, Collect The Cash
Disney: Killing It At The Box Office
Gilead: Why The HCV Bull Case Is Bull
Disney: An 'Uptick' At ESPN?
GM: What Will It Take To Rev Up This Stock's Engine?
Gilead: There Is No Silver Lining To Zepatier, Time To Sell
Boeing: The 777 Slow Down Is Now Fully Priced In... It's Time To Fly
Gilead: Competition, Flat Sales, And A Broken Stock
Triumph Group: The Worst House In A Great Neighborhood Still Has Value!
Value Investors Should Back The Diesel Truck Up For Cummins Shares
Disney: Income Engines Are Fueled And Ready To Fly, But Can Investors Get One More Sell Off?
Gilead: 25 Billion Reasons For Investors To Stay The Course - A Major Acquisition Is Coming
Boeing: These 3 Things Could Drive Shares Lower Tomorrow
Gilead: What Will It Take For Fair Valuation?
Boeing: Inevitable Production Cut In 777 Program Will Present A Buying Opportunity For Long-Term Investors
Chicago Bridge & Iron: Strike While The Iron Is Cold
Boeing: Will The Cash Flow Dream Become An Execution Nightmare?
Disney's Studio Entertainment Segment Poised For Huge FY '16 Box Office Gains
Disney: Will Cord Cutters Cut Disney's Growth Potential?
Disney: This Is What You Should Have Been Waiting For
Gilead: The HCV Market Is Far From Mature
Disney: A Pullback Is Coming For This 'Must Own' Company
Gilead: The Design Of The Discounts
Disney: Closing Out A Stellar Fiscal Year, But Is The Foundation Crumbling?